Clinical Trial Update: Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on prophylaxis for mycoses in high-risk allogeneic stem cell transplant recipients with graft-versus-host disease; the trial statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycoses

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Mycoses | Phase 3 | Status: COMPLETED